Japan Study: How Blood Sugar Control Affects Quality of Life in Type 1 Diabetes

A study from Japan offers a rare, large-scale look at how emotional well-being and quality of life connect to blood sugar control in adults living with Type 1 diabetes (T1D) — and the findings carry important lessons for American patients and their care teams.

What the Researchers Did

Scientists at The Jikei University School of Medicine in Tokyo analyzed data from 528 Japanese adults with T1D as part of the international SAGE study. Participants were divided into three age groups: 26–44 years, 45–64 years, and 65 years and older. Researchers measured both glycemic control (via HbA1c) and four patient-reported outcomes (PROs) — tools that capture how diabetes feels to live with day to day:

• HFS-II — Fear of low blood sugar (hypoglycemia)
• PAID — Emotional distress related to diabetes
• ITSQ — Satisfaction with insulin treatment
• ADDQoL — Overall diabetes-related quality of life

Key Findings

Older patients (65+) reported significantly less fear of hypoglycemia and lower emotional distress than younger patients, while reporting higher satisfaction with their insulin therapy. Across all age groups, patients who achieved an HbA1c below 7.0% — equivalent to an estimated average blood glucose of roughly 154 mg/dL — reported greater satisfaction with how well their treatment controlled their blood sugar. This held true whether patients were working toward the standard HbA1c target or a personalized, less stringent goal set by their doctor.

Importantly, overall quality of life scores were similar across age groups, suggesting that while younger patients experience more anxiety and distress, their broader sense of life quality is not necessarily worse.

Why Does Age Make a Difference?

The researchers suggest that older patients may feel less distress partly because their doctors set less stringent blood sugar targets — a recognized best practice to reduce hypoglycemia risk in older adults. This flexibility may reduce anxiety and increase confidence in their treatment plan.

Why This Matters for US Patients

The American Diabetes Association (ADA) similarly recommends an HbA1c goal of below 7.0% for most non-pregnant adults with T1D, while supporting individualized targets for older patients or those prone to hypoglycemia. This Japanese research reinforces that meeting your personal target — not just a population-wide benchmark — is what drives treatment satisfaction.

For younger American adults with T1D, these findings are a reminder that diabetes distress and fear of lows are real, measurable burdens that deserve attention from care teams — not just HbA1c numbers at every appointment. Tools like the PAID questionnaire are increasingly used in US diabetes clinics but remain underutilized. Asking your provider about a diabetes distress screening could be a meaningful first step.

Finally, the global consistency of these findings — drawn from a very different healthcare system and cultural context — strengthens the case that psychosocial support is a universal need in T1D care, not a uniquely American concern.

Citation

Nishimura, Shimada, Abiru. "Association between glycemic control and patient-reported outcomes in adults with type 1 diabetes in Japan: the SAGE study subanalysis." Diabetology International, 2024. PMID: 38524926. DOI: 10.1007/s13340-023-00668-4